img

Global Womens Health Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Womens Health Market Research Report 2024

Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years.
According to MRAResearch’s new survey, global Womens Health market is projected to reach US$ 44780 million in 2033, increasing from US$ 31880 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Womens Health market research.
Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Womens Health market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Bayer
Merck
Pfizer
Teva Pharmaceutical
Agile Therapeutics
Amgen
Apothecus Pharmaceutical
AstraZeneca
Blairex Laboratories
Bristol-Myers Squibb
Ferring
Segment by Type
Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovary Syndrome
Infertility
Menopause
Others

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Womens Health report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Womens Health Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Postmenopausal Osteoporosis
1.2.3 Endometriosis
1.2.4 Polycystic Ovary Syndrome
1.2.5 Infertility
1.2.6 Menopause
1.2.7 Others
1.3 Market by Application
1.3.1 Global Womens Health Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Womens Health Market Perspective (2018-2033)
2.2 Womens Health Growth Trends by Region
2.2.1 Global Womens Health Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Womens Health Historic Market Size by Region (2018-2023)
2.2.3 Womens Health Forecasted Market Size by Region (2024-2033)
2.3 Womens Health Market Dynamics
2.3.1 Womens Health Industry Trends
2.3.2 Womens Health Market Drivers
2.3.3 Womens Health Market Challenges
2.3.4 Womens Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Womens Health Players by Revenue
3.1.1 Global Top Womens Health Players by Revenue (2018-2023)
3.1.2 Global Womens Health Revenue Market Share by Players (2018-2023)
3.2 Global Womens Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Womens Health Revenue
3.4 Global Womens Health Market Concentration Ratio
3.4.1 Global Womens Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Womens Health Revenue in 2022
3.5 Womens Health Key Players Head office and Area Served
3.6 Key Players Womens Health Product Solution and Service
3.7 Date of Enter into Womens Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Womens Health Breakdown Data by Type
4.1 Global Womens Health Historic Market Size by Type (2018-2023)
4.2 Global Womens Health Forecasted Market Size by Type (2024-2033)
5 Womens Health Breakdown Data by Application
5.1 Global Womens Health Historic Market Size by Application (2018-2023)
5.2 Global Womens Health Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Womens Health Market Size (2018-2033)
6.2 North America Womens Health Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Womens Health Market Size by Country (2018-2023)
6.4 North America Womens Health Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Womens Health Market Size (2018-2033)
7.2 Europe Womens Health Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Womens Health Market Size by Country (2018-2023)
7.4 Europe Womens Health Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Womens Health Market Size (2018-2033)
8.2 Asia-Pacific Womens Health Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Womens Health Market Size by Region (2018-2023)
8.4 Asia-Pacific Womens Health Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Womens Health Market Size (2018-2033)
9.2 Latin America Womens Health Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Womens Health Market Size by Country (2018-2023)
9.4 Latin America Womens Health Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Womens Health Market Size (2018-2033)
10.2 Middle East & Africa Womens Health Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Womens Health Market Size by Country (2018-2023)
10.4 Middle East & Africa Womens Health Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Womens Health Introduction
11.1.4 Allergan Revenue in Womens Health Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Womens Health Introduction
11.2.4 Bayer Revenue in Womens Health Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Womens Health Introduction
11.3.4 Merck Revenue in Womens Health Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Womens Health Introduction
11.4.4 Pfizer Revenue in Womens Health Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Detail
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical Womens Health Introduction
11.5.4 Teva Pharmaceutical Revenue in Womens Health Business (2018-2023)
11.5.5 Teva Pharmaceutical Recent Development
11.6 Agile Therapeutics
11.6.1 Agile Therapeutics Company Detail
11.6.2 Agile Therapeutics Business Overview
11.6.3 Agile Therapeutics Womens Health Introduction
11.6.4 Agile Therapeutics Revenue in Womens Health Business (2018-2023)
11.6.5 Agile Therapeutics Recent Development
11.7 Amgen
11.7.1 Amgen Company Detail
11.7.2 Amgen Business Overview
11.7.3 Amgen Womens Health Introduction
11.7.4 Amgen Revenue in Womens Health Business (2018-2023)
11.7.5 Amgen Recent Development
11.8 Apothecus Pharmaceutical
11.8.1 Apothecus Pharmaceutical Company Detail
11.8.2 Apothecus Pharmaceutical Business Overview
11.8.3 Apothecus Pharmaceutical Womens Health Introduction
11.8.4 Apothecus Pharmaceutical Revenue in Womens Health Business (2018-2023)
11.8.5 Apothecus Pharmaceutical Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Womens Health Introduction
11.9.4 AstraZeneca Revenue in Womens Health Business (2018-2023)
11.9.5 AstraZeneca Recent Development
11.10 Blairex Laboratories
11.10.1 Blairex Laboratories Company Detail
11.10.2 Blairex Laboratories Business Overview
11.10.3 Blairex Laboratories Womens Health Introduction
11.10.4 Blairex Laboratories Revenue in Womens Health Business (2018-2023)
11.10.5 Blairex Laboratories Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Womens Health Introduction
11.11.4 Bristol-Myers Squibb Revenue in Womens Health Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Ferring
11.12.1 Ferring Company Detail
11.12.2 Ferring Business Overview
11.12.3 Ferring Womens Health Introduction
11.12.4 Ferring Revenue in Womens Health Business (2018-2023)
11.12.5 Ferring Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Womens Health Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Postmenopausal Osteoporosis
Table 3. Key Players of Endometriosis
Table 4. Key Players of Polycystic Ovary Syndrome
Table 5. Key Players of Infertility
Table 6. Key Players of Menopause
Table 7. Key Players of Others
Table 8. Global Womens Health Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Womens Health Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Womens Health Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Womens Health Market Share by Region (2018-2023)
Table 12. Global Womens Health Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Womens Health Market Share by Region (2024-2033)
Table 14. Womens Health Market Trends
Table 15. Womens Health Market Drivers
Table 16. Womens Health Market Challenges
Table 17. Womens Health Market Restraints
Table 18. Global Womens Health Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Womens Health Market Share by Players (2018-2023)
Table 20. Global Top Womens Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Womens Health as of 2022)
Table 21. Ranking of Global Top Womens Health Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Womens Health Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Womens Health Product Solution and Service
Table 25. Date of Enter into Womens Health Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Womens Health Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Womens Health Revenue Market Share by Type (2018-2023)
Table 29. Global Womens Health Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Womens Health Revenue Market Share by Type (2024-2033)
Table 31. Global Womens Health Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Womens Health Revenue Market Share by Application (2018-2023)
Table 33. Global Womens Health Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Womens Health Revenue Market Share by Application (2024-2033)
Table 35. North America Womens Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Womens Health Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Womens Health Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Womens Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Womens Health Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Womens Health Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Womens Health Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Womens Health Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Womens Health Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Womens Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Womens Health Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Womens Health Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Womens Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Womens Health Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Womens Health Market Size by Country (2024-2033) & (US$ Million)
Table 50. Allergan Company Detail
Table 51. Allergan Business Overview
Table 52. Allergan Womens Health Product
Table 53. Allergan Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 54. Allergan Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Womens Health Product
Table 58. Bayer Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Merck Company Detail
Table 61. Merck Business Overview
Table 62. Merck Womens Health Product
Table 63. Merck Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 64. Merck Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Womens Health Product
Table 68. Pfizer Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Teva Pharmaceutical Company Detail
Table 71. Teva Pharmaceutical Business Overview
Table 72. Teva Pharmaceutical Womens Health Product
Table 73. Teva Pharmaceutical Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 74. Teva Pharmaceutical Recent Development
Table 75. Agile Therapeutics Company Detail
Table 76. Agile Therapeutics Business Overview
Table 77. Agile Therapeutics Womens Health Product
Table 78. Agile Therapeutics Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 79. Agile Therapeutics Recent Development
Table 80. Amgen Company Detail
Table 81. Amgen Business Overview
Table 82. Amgen Womens Health Product
Table 83. Amgen Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 84. Amgen Recent Development
Table 85. Apothecus Pharmaceutical Company Detail
Table 86. Apothecus Pharmaceutical Business Overview
Table 87. Apothecus Pharmaceutical Womens Health Product
Table 88. Apothecus Pharmaceutical Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 89. Apothecus Pharmaceutical Recent Development
Table 90. AstraZeneca Company Detail
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Womens Health Product
Table 93. AstraZeneca Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 94. AstraZeneca Recent Development
Table 95. Blairex Laboratories Company Detail
Table 96. Blairex Laboratories Business Overview
Table 97. Blairex Laboratories Womens Health Product
Table 98. Blairex Laboratories Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 99. Blairex Laboratories Recent Development
Table 100. Bristol-Myers Squibb Company Detail
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Womens Health Product
Table 103. Bristol-Myers Squibb Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Ferring Company Detail
Table 106. Ferring Business Overview
Table 107. Ferring Womens Health Product
Table 108. Ferring Revenue in Womens Health Business (2018-2023) & (US$ Million)
Table 109. Ferring Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Womens Health Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Womens Health Market Share by Type: 2022 VS 2033
Figure 3. Postmenopausal Osteoporosis Features
Figure 4. Endometriosis Features
Figure 5. Polycystic Ovary Syndrome Features
Figure 6. Infertility Features
Figure 7. Menopause Features
Figure 8. Others Features
Figure 9. Global Womens Health Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Womens Health Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Womens Health Report Years Considered
Figure 15. Global Womens Health Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Womens Health Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Womens Health Market Share by Region: 2022 VS 2033
Figure 18. Global Womens Health Market Share by Players in 2022
Figure 19. Global Top Womens Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Womens Health as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Womens Health Revenue in 2022
Figure 21. North America Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Womens Health Market Share by Country (2018-2033)
Figure 23. United States Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Womens Health Market Share by Country (2018-2033)
Figure 27. Germany Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Womens Health Market Share by Region (2018-2033)
Figure 35. China Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Womens Health Market Share by Country (2018-2033)
Figure 43. Mexico Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Womens Health Market Share by Country (2018-2033)
Figure 47. Turkey Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Womens Health Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Allergan Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 50. Bayer Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 53. Teva Pharmaceutical Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 54. Agile Therapeutics Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 55. Amgen Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 56. Apothecus Pharmaceutical Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 58. Blairex Laboratories Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 60. Ferring Revenue Growth Rate in Womens Health Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed